Oncology Early Phase / Multiple Disease Site Hematologic Malignancies Early Phase Team Lymphoma NHL CLL/SLL Relapsed/Refractory 2 or more prior lines
Categories
Protocols
SCHRODINGER-SGR-1505-101 Phase I OPEN TO ACCRUAL
A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Patients with Mature B-Cell Malignancies